Dr-Diabetic-Food

Sierra Leone’s Inadequate Data Makes it Difficult to Know The Prevalence of Diabetes in The Country

Diabetes mellitus (DM) is a global health catastrophe that affects how the body processes sugar due to either lack of the hormone insulin or issues that makes the body resistant to the action of insulin. Insulin is the hormone in our body that stores excess glucose to glycogen and helps the cells of our body absorb glucose for energy.

DM leads to devastating complications like stroke, heart issues, amputation, blindness etc, if left untreated or unattended to.

People with diabetes who lead a normal life have a full-time job to ensure their sugar level remains stable. But in as much as such affected persons try endlessly to prevent sugar levels from escalating, they must also work so hard to prevent sugar levels not to go too low to prevent complications like coma.

People in Africa face lots of difficulties in terms of accessibility to diabetes care. Marginalised communities are unaware of DM and its consequences, and they must pay out of pocket for their drugs and continuity of care.
In a country like Sierra Leone, most tertiary and secondary facilities are clustered in the city, leaving villagers accessing health care at community health centres which lack the necessary expertise to manage and prevent DM. Unfortunately, many Africans are diagnosed late after complications have already set in.

There are about 4 types of DM: Type 1, which is insulin dependent DM; Type 2, which is non-insulin dependent DM; Type 3, which is DM affecting women during pregnancy; and Type 4, which is DM due to drugs and other diseases affecting the pancreas.

Burden of DM in the Africa region

According to the International Diabetes Federation (IDF), the Africa region represents the highest proportion with undiagnosed DM, with 60% of its adults having it without knowing about their condition.

Below is a concise representation of types 1 & 2 diabetes in Africa and projections of prevalence of diagnosed and undiagnosed diabetes by 2030/2045, as well as projected government health expenditure by 2030/2045.

In summary, it is estimated in 2019 that 19 million people were living with diabetes in Sub-Saharan Africa (SSA) and this figure was expected to skyrocket to 47 million by 2045. Among those with undiagnosed DM, 12 million people have diabetes unknowing to them and 366,200 people in Africa die because of DM.

The 8th edition of the Diabetes Atlas report estimates that 77% of all diabetes related deaths worldwide occur in SSA, in people under 60 years of age (IDF atlas 2017).

This information is quite a bit alarming, but the good news is, diabetes is a preventable disease if we adopt healthy lifestyle behaviours.

A systematic analysis on prevalence and sub-regional distribution of undiagnosed diabetes mellitus among adults in African countries reveal that West Africa has the highest burden of undiagnosed DM. Nigeria represents the top five countries in Africa with high prevalence of DM.

In Sierra Leone, inadequate data makes it difficult to ascertain national prevalence of DM.It is inevitable that uncontrolled endemic and epidemic diseases affecting a nation can extremely place health expenditure burden on governments, especially with our fragile health system in Africa.

According to IDF 2019, government expenditure on health due to diabetes is US$10 billion and is projected to increase up to US$17 billion by 2045.

What could be the cause for the time-ticking-diabetes-bomb that awaits us?

DM is characterized as one of the leading non-communicable diseases (NCDs) in Africa. DM itself leads to increased risk of leading causes of communicable diseases like Human Immunodeficiency Virus (HIV), Tuberculosis (TB), viral hepatitis, pneumonia and Covid-19 infections (Davies K et al., 2020).

Food stuff like these increase the risk of diabetes. Image source unknown
Plausible reasons for the increasing prevalence of DM in Africa are due to common chronic communicable diseases on the continent, which cause inflammatory conditions, leading to organ dysfunction and damage. Even some drugs used to treat, for instance, HIV and TB, could also lead to DM (Davies K et al., 2020).

In addition, obesity appears to be a major issue among urban women aged 15–49 years, as demonstrated from the results of demographic and health survey from 24 African countries (Neupane S et.al, 2016). These women have high risk of developing gestational diabetes in the future, which in turn predisposes their poor babies to diabetes at adulthood or even childhood.

A study was conducted by me in 2017, to assess the risk of developing DM among adults in Freetown. A population size of 1013 was randomly selected, and the prevalence of participants to be at high risk of developing Type 2 DM (T2DM) was 17.8%. Though more rigorous and extensive research is needed to ascertain this, the study highlighted that age, gender, occupation, high waist circumference, hypertension and family history are associated risk factors that yielded statistical significance.

Body Mass Index (BMI) categorization by gender shows that more females (77%) had higher BMI compared to males (53%). Also, more females (19.2%) compared to males (8.1%) were found to have a high waist circumference (WC) which denotes central obesity. This study conforms to a systemic review and metanalysis conducted by Davies A et.al, in Nigeria, which demonstrated that there were 21 million and 12 million overweight and obese persons respectively, in the Nigerian population aged 15 years or more in 2020, and more females were over-weight and in the obese category compared to males.

Previous studies have established that West African Lineage is associated with greater BMI and total body fat. Many studies have shown distinct evidence to confirm that obesity is a major risk factor for T2DM.

Obesity is on the increase in Africa, due to adoption of westernized culture, urbanization, growth in economy, sedentary lifestyle, and introduction of processed foods (Searcey & Richtel 2017).

It is indeed poignant that improved standards of living is driving us to make poor health life choices. In Sierra Leone or in some regions in Africa, obesity is a sign of affluence, dignity, and respect (Janzon E et al., 2015).

Despite this fact, let us not forget that diabetes respects no socioeconomic status or boundaries in general. In a country like Sierra Leone, which probably other countries in the region can relate, people can hardly afford to buy fruits and vegetables. Healthy foods are not produced abundantly in our country, and the poor will continue to be deprived from eating healthy foods that could prevent the occurrence of diabetes. We are highly dependent on importation of most of our food items, even salt and sugar. It has reached a point where imported foods can be cheaper that home grown foods.

Poverty, which is our biggest killer, forces us to eat unhealthy foods to fill our stomach. Adoption of the Mediterranean diet, which mainly consists of fruits, vegetables, nuts, wholegrains and fish have been shown to prevent diabetes.

People with diabetes can prolong their health with the proper diet involving these kind of food stuffs. Image source unknown
Regular physical activity is undeniably relevant in the prevention and management of diabetes. The American Diabetes Association recommends 150 minutes of regular physical activity per week to prevent and manage DM.

Our road networks in Africa could be a turn off for citizens to be engaged in walking and jogging. That needs to be changed, citizens of African countries have every right to be able to exercise conveniently whenever and wherever they find themselves. People living in the rural setting walk miles to reach their farm or place of work, whereas in the urban setting we just rely on transportation. The latter provides such a convenience to people in the urban setting combined with the chair we sit in the whole day at work, highly encouraging us not to be active.

Among other factors that is causing high disease burden and undiagnosed cases in Africa are lack of motivation needed for health workers to provide service; shortage of health work force, brain drain, lack of organized structure for chronic disease care, fewer tertiary care hospitals, lack of awareness of prevalent diseases among the population and inappropriate health care information systems

Strategies to mitigate the epidemic in Africa

Without leadership, governance, financing, health workforce, health information systems, supply chains, and service delivery, we will continue to suffer from diabetes and many chronic diseases. Because diabetes is a lifelong disease and is associated with acute and chronic complications that could cause multiple organ damage, it requires several multi-faceted approaches to reduce the burden of the disease from a public health point of view.

Interventions to target obesity include nutrition labelling; marketing restrictions of unhealthy foods and beverages to kids; fruit and vegetable subsidies; physical activity policies and social marketing campaigns. WHO member states around the world, including South Africa, have committed to halt the rise of obesity and diabetes, reduce premature deaths from NCDs by 25% by 2025 and one-third by 2030. The latter target is in line with the Sustainable Development Goals.

How many countries in Africa are really committed to keep that ambitious promise? Many countries in Africa will be hesitant to execute laws that would prevent DM due to political reasons. In Sierra Leone, selling of alcohol occurs in the streets so freely that it can easily be accessed by kids. There are foreign companies that manufacture high percentage of alcohol beverages with no one to hold them accountable. Alcohol overuse and substance abuse is a rising pandemic that also needs to be addressed. Chronic alcohol use is an associated risk factor for the development of diabetes. Studies have shown a genetic predisposition to increased risk of DM among heavy alcohol users (Jang et al 2019).

As we know, diabetes was known as the disease of the rich. Though it is still affecting people living in developed countries, many strategies are being put in place to help protect their citizens. The political will is there. In Africa, some of our presidents themselves are obese, they are diabetic or are at high risk of developing T2DM. Politicians of African countries, including the health ministers themselves, will rather fly to the most sophisticated countries to seek medical care. They themselves do not trust their health system which they are supposed to fix, leaving their own citizens vulnerable and deprived of the basic health care they need.

With the exception of a few, the health system of Africa is highly fragile. In Sierra Leone, for example, we keep on putting the blame for our poor health system on the [1991-2200 civil war, Ebola and now Covid-19 pandemic.

If we do not finance our health system to achieve universal health coverage, life expectancy of Africans will remain low, with the potential of holding back economic growth.

Many people are pushed to extreme poverty when they must pay out of pocket for diseases other than TB, HIV.

A multipronged urgent control measure is needed to diagnose people at risk of developing diabetes to prevent subsequent complications of the disease that is affecting quality of life of people globally.

This is the time to take action towards strengthening our health system in Africa. We need to create a donor-independent health system, otherwise emerging and remerging infectious diseases will continue to claim our lives, further exposing our fragile health system. Sadly, this is a reality which we cannot ignore. Diversion of resources towards communicable diseases, away from non-communicable diseases, and provision of essential health services, further leads to more morbidity and mortality. Africa needs to wake up!

14-a

Factors Associated with HBsAg Seropositivity among Pregnant Women Receiving Antenatal Care at 10 Community Health Centers in Freetown, Sierra Leone: A Cross-Sectional Study

By Dr Manal Ghazzawi

Hepatitis B (HBV) is a major public health threat in Sierra Leone. Pregnant women are disproportionately impacted, yet little is known about the epidemiology of HBV in this group. We conducted a cross-sectional study of pregnant women aged ≥16 years receiving antenatal care across 10 community health centers in Freetown from July to September 2021 to assess the prevalence and associated factors of HBsAg seropositivity. A logistic regression was used to identify the predictors of HBsAg seropositivity. In total, 394 pregnant women were screened. The mean age was 24.4 ± 4.9 years, 78.2% were married, and 47.2% were in the second trimester. Only 1% had received the HBV vaccine. The prevalence of HBsAg was 7.9%, while HIV was 5.8% and HIV/HBV co-infection was 0.3%. Regarding high-risk practices, 76.6% reported female genital circumcision, 41.9% ear piercing, 29.0% endorsed multiple sexual partners, and 23.6% reported sexually transmitted infections. In the logistic regression analysis, having a husband/partner with HBV (adjusted odds ratio (aOR): 6.54; 95% CI: [1.72–24.86]; p = 0.006) and residing in Central Freetown (aOR: 4.00; 95% CI: [1.46–11.00]; p = 0.007) were independently associated with HBsAg seropositivity. Our findings support the scaling up of HBV services to target pregnant women and their partners for screening and vaccination to help reduce mother-to-child transmission rates in Sierra Leone.
https://www.researchgate.net/publication/358557495_Factors_Associated_with_HBsAg_Seropositivity_among_Pregnant_Women_Receiving_Antenatal_Care_at_10_Community_Health_Centers_in_Freetown_Sierra_Leone_A_Cross-Sectional_Study

5-c

Assessing diabetic patients at risk of developing foot ulcers in Freetown, Sierra Leone

By Dr Manal Ghazzawi

Introduction: Diabetes Mellitus is a global health issue, though current prevalence data is lacking Sierra Leone has an increasing number of diagnosed and undiagnosed diabetes. Lack of education and self-care, poor adoption of healthy lifestyle may be the main factors leading to an increased risk of diabetic foot ulcers. 

Objectives: To identify patients with diabetes at risk of developing foot ulcers, diabetic neuropathy, peripheral artery disease and to investigate the association between independent risk factors involved in development of foot ulcers and other clinically related factors. 

Methods: Study was done at two sites, Connaught hospital and a clinic in Freetown. A standardized questionnaire was administered for risk assessment of diabetic ulcers. A total of 231 participants (Ages 45-75 years) were recruited via systematic random sampling. Descriptive statistics was used to analyze data using SPSS. 

Results: Majority of participants (64.5%) were diagnosed with diabetes within 1-5 years, 5.5% and 13.4% had eye and kidney disease respectively. Protective sensation evaluation revealed that 38.5% had loss of protective sensation and 19% had suspected peripheral arterial disease with absent pulse at the posterior tibial artery and dorsalis pedis. Age, occupation, years since diagnosis and type of diabetes was significantly associated with high risk of developing diabetic foot ulcers with a P value < 0.005. Risk Categorization of participants revealed 76% at low risk while those at moderate, high and highest risks were 20%, 17% and 3.5% respectively. Individuals with prior kidney disease, eye problems and previous history of amputation had greater loss of protective sensation, absent pulse, and tingling sensation at extremities. 

Conclusion: There’s great need for health care workers to become diabetes educators to offer proper services like diabetes foot examination to prevent diabetes ulcers which leads to amputation. Detecting diabetic patients at risk for diabetic foot ulcers will go a long way to prevent future amputations and other associated complications.

DOI URL: https://doi.org/10.53388/FTHC20210510002

image

To Know Hepatitis Is To Eradicate It

Hepatitis B is claiming lives of Sierra Leoneans, it is becoming a public health problem. Already it is a global health concern. Globally 350-400 million people are chronically infected with hepatitis B virus (defined as hepatitis B surface antigen positive for at least 6 months). Worldwide, more than 686,000 people die every year due to complications of hepatitis B, including cirrhosis and liver cancer. Though data does not exist to verify this, Sierra Leone has a higher prevalence of hepatitis B than C. Due to the paucity of research in Sierra Leone, we do not know the current prevalence of hepatitis B in the country. However few statistics exist for different population groups; for children affected with hepatitis B ranges between 1.3% – 1.6%, health care workers 8.7%, pregnant females 11.3% and blood donors at Connaught hospital 15.2%.

During my training as a clinical pharmacist, I came across many patients infected with the virus at the Joint Medical Unit within the military hospital. To make matters worse most of these patients are co- infected with HIV. Adding more burden to the disease, because they will have to deal with the side effects of their drugs, and debilitating symptoms of both diseases. Statistics in Sierra Leone has confirmed, that up to 22% of those infected with hepatitis B are also living with HIV/AIDs.

Hepatitis B is a viral infection that is transmitted through blood and body fluids such as vaginal fluids and semen. Hence, it is transmitted through sex, sharing of contaminated sharp object (needles, razors e.t.c), blood transfusion, and mother to child during birth. There is not much evidence to show whether it is transmitted by sweat or sharing of kitchen utensils or even by kissing. The hepatitis B virus can survive outside the body for at least 7 days. During this time, the virus can still cause infection if it enters the body of a person who is not protected by the vaccine. The incubation period of the hepatitis B virus is 75 days on average but can vary from 30 to 180 days. Due to the long incubation period, it is possible for an infected individual to be spreading the disease because he/she is asymptomatic. This is how the virus might be spreading at a faster rate, among many other factors. The virus may be detected within 30 to 60 days after infection and can persist and develop into chronic hepatitis B after 6 months.

People at risk of developing hepatitis B are:

  • Infants born to infected mothers
  • Sex partners of infected persons
  • Persons with multiple sex partners
  • Persons with a sexually transmitted disease (STD)
  • Men who have sex with men
  • Injection drug users
  • Household contacts of infected persons
  • Healthcare and public safety workers exposed to blood on the job
  • Hemodialysis patients
  • Residents and staff of facilities for developmentally disabled persons
  • Travelers to regions with intermediate or high rates of Hepatitis B (HBsAg prevalence of ≥2%)

Signs and Symptoms:

  • Fever
  • Loss of appetite
  • Muscle pain and joint pain
  • Upper right abdominal pain
  • Dark urine
  • Clay colored stool

Complications of chronic active hepatitis include chronic liver disease, cirrhosis of the liver and liver cancer.

Hepatitis B infection continues to rise among Sierra Leoneans and will continue to rise if precautionary measures are not taken among already infected patients and uninfected individuals. Also, some health facilities misdiagnose the infection on clinical grounds for malaria and typhoid since these infections manifest mimicking symptoms like fever, malaise, joint pain, loss of appetite etc. This translates into infected patients  being treated wrongly with antimalarial agents, IV fluids and antibiotics leading to antimicrobial resistance, increased cost for patient, and reduced quality of life. Consistent misdiagnosis of this infection will lead to increased viral load, causing chronic infective hepatitis B with symptoms showing early or late signs of liver damage. The national hepatitis task force, has formulated a treatment guideline in the management of viral Hepatitis (VH). Until that guideline is released to all health care facilities in the country, it is important that most health care workers educate themselves about prevention and proper management of VH, instead of over prescribing antiviral drugs when it is not needed and when they are not authorized to do so. I cannot overemphasize the fact that not all those infected with the virus need an antiviral medication. I advise the public to seek the right health care advice, from specialists before accepting treatment not only for hepatitis but for any other disease.

For clinicians to decide whether to commence therapy or not, certain diagnostic criteria according to international guidelines must be met. Diagnostic tests such as liver function tests and identification of stage of the hepatitis B infection are available in Sierra Leone (but not easily accessible at all public hospitals nationwide). More sophisticated tests like viral load determination, which is a diagnostic criterion in the management of hepatitis B is provided by a private facility, which costs about $160. This is nerve wrecking for people who cannot afford it and might need more than 3 months of their salary to pay for that.  Thanks to Partners in Health at the Koidu Government hospital which is offering tremendous support in diagnosis and management for free.

Hepatitis B can only be managed but not curable. Those that are lucky with a strong immune system, can get infected and clear the virus completely and recover. Supportive treatment is only required for managing acute hepatitis B infection. Less than 4% of those infected become chronic, within this 4% some will become immune tolerant or have inactive chronic infection without evidence of active disease, hence asymptomatic and can be noninfectious. Those with chronic active infection can have symptoms of liver disease which is treated with antiviral medications to suppress viral load and disease progression. Patients infected with this virus should continue to eat a healthy balanced diet, avoid drinking alcohol and drugs that are toxic to the liver.

The best way to prevent hepatitis is to get vaccinated. The vaccine is not widely available and affordable, but can be accessible at some facilities, especially in Freetown. For those that cannot afford buying the vaccine, the best they could do, to stay out of trouble is sticking with one partner, use of condoms during sex, avoid sharing of sharp objects and blood transfusion from unscreened blood.

Introduction of the birth dose of hepatitis B vaccine for all babies have been introduced in many countries including Africa. China CDC in collaboration with the Ministry of Health and Sanitation (MOHS) is to implement that in Sierra Leone. However, the MOHS already provides HBV vaccine which is included in the pentavalent vaccine given at 6th, 10th and 14th week of a baby’s life. Adoption of the birth dose is part of the global elimination strategy, to prevent mother-to-child transmission where a baby needs to be vaccinated within 12-24 hrs. This strategy is particularly important in prevention of new infections, because 90% of babies born from infected mothers will develop chronic hepatitis B which eventually could lead to liver cancer at their adult age.

The Ministry of Health and Sanitation (MOHS) needs to have a  Viral Hepatitis (VH) elimination action plan where its focus is on 4 main goals:

Goal 1: To prevent new viral hepatitis infections, through awareness raising, capacity building of HCWs, address data gaps through surveillance, preventive for vulnerable groups,

Goal 2: Reduce deaths and improve the health of people living with VH by swift identification of those infected with VH. Improved access to quality care and treatment among those infected with VH, those coinfected with HIV/AIDS and intravenous drug users,

Goal 3: Reduce VH health disparities by partnering with and educating priority populations and their communities about viral hepatitis and the benefits of available prevention, care, and treatment.

Goal 4: Coordinate, monitor, and report on implementation of VH activities by strengthening timely availability and use of data.

Government and private health facilities should be able to provide more sophisticated laboratory investigations, that will aid in the proper management of Hepatitis B in Sierra Leone. Moreover, all health professionals should be dedicated to educating the public by increasing awareness about the disease and its prevention.

This is not only government’s fight, but all of us, it takes the support and commitment of a broad mix of stakeholders i.e. the scientific community, community leaders, policy makers and the private sector. It is amazing how our national collective effort can create a massive impact towards elimination of VH by 2030.